IP Library › Granted Patent US 10,953,156
Granted Patent B2
US 10,953,156 · App. 16/571,591 · Granted Mar 23, 2021

Hemoglobin display and patient treatment

Inventors: Ammar Al-Ali (San Juan Capistrano, CA); Massi Joe E. Kiani (Laguna Niguel, CA); Michael O'Reilly (Dana Point, CA)
Assignee: Masimo Corporation
A61M5/1723A61B5/1455A61B5/14546A61B5/14551A61B5/416A61B5/4836A61B5/6826A61B5/7257A61B5/742A61M1/024A61M1/1603A61B5/14532A61B5/14552A61M37/00A61M2230/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,953,156
App. No.
16/571,591
Granted
Mar 23, 2021
Kind
B2
Abstract

The present disclosure describes embodiments of a patient monitoring system and methods that include the measure and display of hemoglobin statistics. In an embodiment, total hemoglobin trending is displayed over a period of time. Statistics can include frequency domain analysis, which may be unique for each patient monitored. The total hemoglobin trending and/or statistics can further be used to help control the treatment of a patient, such as being used to control IV administration.

Claims (19)

1. A physiological monitor connected with a fluid delivery controller, said physiological monitor comprising:

a noninvasive sensor configured to emit energy into a measurement site of a patient and detect the energy attenuated by the patient measurement site; and

one or more hardware processors configured to:

determine a plurality of total hemoglobin measurements over a first time period based on the detected attenuated energy;

perform a frequency transform on the determined plurality of total hemoglobin measurements;

determine a physiological condition of the patient based on the frequency transformed total hemoglobin measurements; and

transmit an indication of the determined physiological condition to the fluid delivery controller.

2. The physiological monitor of claim 1 , wherein the fluid delivery controller and the physiological monitor are included in a single unit.

3. The physiological monitor of claim 1 , wherein fluid delivery controller is configured to control a rate or amount of fluid administered to the patient from the fluid bag based on the indication.

4. The physiological monitor of claim 1 , wherein transmission is through a wireless communication.

5. The transfusion system of claim 1 , wherein transmission is through a wired communication.

6. A physiological monitoring method comprising:

determine a plurality of total hemoglobin measurements over a first time period based on detected attenuated energy from a noninvasive sensor attached to a measurement site of a patient;

performing a frequency transform on the determined plurality of total hemoglobin measurements;

determining a physiological condition of the patient based on the frequency transformed total hemoglobin measurements; and

transmitting an indication of the determined physiological condition to a fluid delivery controller.

7. The physiological monitoring method of claim 6 , further comprising controlling a rate or amount of fluid administered to the patient from a fluid bag based on the indication.

8. The physiological monitoring method of claim 6 , wherein the transmission is through a wireless communication.

9. The physiological monitoring method of claim 6 , wherein the transmission is through a wired communication.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2024
From: AL-ALI, AMMAR; KIANI, MASSI JOE E.; O'REILLY, MICHAEL
To: MASIMO CORPORATION
Reel/Frame 068116/0266 →
Continuity (8)
Continuation 15789357 · Oct 20, 2017
Continuation 15184950 · Jun 16, 2016
Continuation 14714691 · May 18, 2015
Continuation 14064026 · Oct 25, 2013
Continuation 12783436 · May 19, 2010
Provisional Application 61180018 · May 20, 2009
Provisional Application 61221435 · Jun 29, 2009
Related Publication 20200246544A1 · Aug 6, 2020
Cited By (1)
US 12,318,580